Related Experiment Video
Updated: Aug 15, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
Elie G Abu Jawdeh1, Carl E Hunt2, Eric Eichenwald3
1University of Kentucky, Lexington, KY, USA. elie.abujawdeh@uky.edu.
Insights
The COVID-19 pandemic significantly reduced parent approach for infant consent in a clinical trial, with enrollment rates only partially recovering post-pandemic. Consent rates per approached parent remained stable.
Area of Science:
- Clinical Trials
- Epidemiology
- Public Health
Background:
- The COVID-19 pandemic presented unprecedented challenges to healthcare systems globally.
- Clinical trial operations, particularly subject recruitment, were significantly impacted by public health measures and parental concerns.
Purpose of the Study:
- To evaluate the impact of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial.
- To assess changes in the ability to approach parents for consent and their subsequent consent rates.
Main Methods:
- A multicenter randomized controlled trial design was employed.
- Enrollment data, including the number of eligible infants approached and consented, were analyzed across five distinct epochs: baseline, peak pandemic, and recovery phases.
Main Results:
- Parental approach rates decreased dramatically from 95.4% at baseline to 13.1% during the peak pandemic.
- Enrollment recovery was incomplete, with post-pandemic approach rates at 84.9%.
- Despite reduced approach rates, the consent rate among approached parents remained statistically unchanged.
Conclusions:
- The COVID-19 pandemic severely hindered the ability to approach parents for infant consent in clinical trials.
- Partial recovery in approach rates has been observed, but challenges in investigator-parent interactions persist.
- Maintaining trial integrity requires adaptive strategies to overcome pandemic-related recruitment barriers.
Objective:
Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial.
Study Design:
We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery.
Result:
The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the study CONCLUSION: The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Bias in Epidemiological Studies
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...

